| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/03/2008 | WO2007145834A3 Benzamide derivatives and uses related thereto |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081824 Substituted piperidines as modulators of chemokine receptor activity |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/03/2008 | US20080081802 Thiazolyl-Dihydro-Indazole |
| 04/02/2008 | EP1904486A2 Processes for the synthesis of 3-isobutylglutaric acid |
| 04/02/2008 | EP1904447A1 Piperidine carboxamide derivate suitable as tachykinin receptor antagonist |
| 04/02/2008 | EP1904435A2 Benzamide derivatives and uses related thereto |
| 04/02/2008 | EP1904057A2 Methods of treatment using hydroquinone ansamycins |
| 04/02/2008 | EP1765771A4 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 04/02/2008 | CN101155780A Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 04/02/2008 | CN101153020A (3S,4R)-4-(fluorophenyl)-3-hydroxymethyl-1-methyl piperidine and split method of antipodism thereof |
| 04/02/2008 | CN100378092C Biphenyl derivatives |
| 04/02/2008 | CN100378072C Heterocyclic methyl sulfone derivative |
| 04/01/2008 | US7351838 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351720 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351718 Muscarinic receptor antagonists; longer duration of action; side effect reduction; high potency; chronic obstructive pulmonary disease; asthma; inhalation; 2-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide |
| 04/01/2008 | US7351717 Substituted pyrrolidine and related compounds |
| 03/27/2008 | WO2007127711A3 Abnormal cannabidiols as agents for lowering intraocular pressure |
| 03/27/2008 | WO2007115943A3 Process for the preparation of an n-alkyl lactam with improved colour quality |
| 03/27/2008 | US20080076927 safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous sytem |
| 03/27/2008 | US20080076807 Treating diseases related to TNF or cytokine overproduction; antitumor agents; autoimmune diseases, neurodegenerative diseases; hydroxamic acid derivatives containing an alpha-aminoacyl moiety such as 4-(2(R)-Benzoylamino-3-naphthalen-2-yl-propionylamino)-N-hydroxy-benzamide |
| 03/27/2008 | US20080076806 Glycine transporter gene 1 (GlyT-1); psychosis, schizophrenia, dementia; activation of NMDA receptors via GlyT-1 inhibition; N-(([(4-chloro-phenyl)-phenyl-methyl]-carbamoyl)-methyl)-4-fluorobenzamide for example |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076799 Piperidinic Derivatives, Pharmaceutic Compositions Containing the Same and Preparation Processes |
| 03/27/2008 | US20080076783 Cycloalkyl Keto Piperidine Tachykinin Receptor Antagonists |
| 03/27/2008 | US20080076769 Norvaline Derivative and Method for Preparation Thereof |
| 03/27/2008 | US20080075891 Chlorofluorobenzene liquid crystal compound, liquid crystal composition and liquid crystal display device |
| 03/27/2008 | DE102006043519A1 4-Phenoxynikotinsäure-Derivate und ihre Verwendung 4-Phenoxynikotinsäure derivatives and their use |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1903034A1 Iminosugar glycoconjugates |
| 03/26/2008 | EP1903023A1 Method for manufacturing arylamines |
| 03/26/2008 | EP1902044A1 5-htx modulators |
| 03/26/2008 | EP1901752A2 Compositions and methods for viral inhibition |
| 03/26/2008 | EP1901746A2 4-fluoro-piperidine t-type calcium channel antagonists |
| 03/26/2008 | EP1613594B1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 03/26/2008 | EP1289527B1 (+)-alpha-(2,3-dimethoxyphenyl)-1(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol or its prodrug to treat dementia or cognitive impairment |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | EP0923553B1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl compounds |
| 03/26/2008 | CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 03/26/2008 | CN101151247A 3,4,5-substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101148435A Method for directly preparing piperidine derivative hydrochlorates by using Pd-C to catalyze and hydrogenate pyridine derivatives |
| 03/26/2008 | CN100377004C Image forming material and ammonium compound |
| 03/25/2008 | US7348448 Substituted phenyl esters; dementia |
| 03/25/2008 | US7348435 Dehydrating a piperidine carboxamide with thionyl chloride; one step process; chemical intermediates in antidepressants, anti-inflammatory and immunomodulators |
| 03/25/2008 | US7348356 enzyme inhibitor for preventing the formation of insoluble Amyloid beta and arresting the production of Amyloid beta; prevention or treatment of such diseases in which the enzyme is involved; compound including a N-alkyl cycloalkyl group |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | US7348318 α-Amino-N-(diaminophosphinyl)lactam derivatives |
| 03/25/2008 | US7348290 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/20/2008 | WO2007109290A3 Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer |
| 03/20/2008 | US20080071088 Drugs for respiratory system disorders; also chemical intermediate for such drugs |
| 03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
| 03/20/2008 | US20080070953 Inhibitors of interleukin-1 beta converting enzyme |
| 03/20/2008 | US20080070951 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | US20080070946 Hydroxymethylbenzothiazoles Amides |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070789 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 03/20/2008 | US20080069851 Substituted n-aminomethylene sulfonamides, production and use thereof as medicaments |
| 03/20/2008 | US20080069789 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers |
| 03/19/2008 | EP1900726A1 Heterocyclic thioesters |
| 03/19/2008 | EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
| 03/19/2008 | EP1899294A1 Therapeutic agents |
| 03/19/2008 | EP1898940A1 Inhibitors of the alpha2beta 1/gpia-iia integrin |
| 03/19/2008 | EP1414453B1 Fexofenadine hydrochloride polymorph |
| 03/19/2008 | EP1363630B1 Kappa opioid receptor ligands |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1307423B1 Processes for the production of fexofenadine |
| 03/19/2008 | CN101146773A 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 03/19/2008 | CN101146764A Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 03/18/2008 | US7345177 Reacting beta -picoline with chlorine in the presence of a dealuminated Mordenite zeolite or a supported palladium catalyst to produce 2-Chloro-5-trichloromethylpyridine |
| 03/18/2008 | US7345175 Biphenyl derivatives |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345051 For controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infections |
| 03/18/2008 | CA2237279C Liquid polyfunctional additives |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029810A1 Phenylguanidine derivative or salt thereof, and pest control agent containing them as active ingredient |
| 03/13/2008 | WO2008012859A3 Process for preparing fexofenadine |
| 03/13/2008 | WO2007146838A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
| 03/13/2008 | US20080064872 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
| 03/13/2008 | US20080064724 Composition Comprising Methylphenidate and Another Drug |
| 03/13/2008 | US20080064716 Biphenyl Integrin Antagonists |
| 03/13/2008 | US20080064706 Piperidine Derivatives as Histamine H3 Receptor Ligands |
| 03/13/2008 | US20080064693 N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064682 1,5-diaryl-3-N-heterocycylcarbonylpyrazoles; antiagglomerants that do not inhibit cyclooxygenases; antiischemic agents |
| 03/13/2008 | US20080060775 8-Oxyl-7,7,9,9-tetramethyl-1,3,8-triaza-spiro[4.5]decane-2,4-dione; antiyellowing agents for lignin |
| 03/13/2008 | CA2662702A1 Difluorinated piperidines for treatment of alzheimer's disease and related conditions |
| 03/12/2008 | EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |